Literature DB >> 30070189

Local outbreak of Streptococcus pneumoniae serotype 12F caused high morbidity and mortality among children and adults.

T Ikuse1, R Habuka2, Y Wakamatsu3, T Nakajima3, N Saitoh1, H Yoshida1, B Chang4, M Morita4, M Ohnishi4, K Oishi5, A Saitoh2.   

Abstract

Pneumococcal serotype replacement is an important issue after the introduction of pneumococcal conjugate vaccine (PCV) in children. After the introduction of 13-valent PCV, the incidence of invasive pneumococcal diseases (IPD) caused by Streptococcus pneumoniae serotype 12F (Sp12F) have increased in some countries; however, an outbreak of Sp12F has not reported in the post-13-valent PCV era. We experienced a local outbreak of Sp12F during March through May 2016 in Tsuruoka city, Japan after the introduction of 13-valent PCV in 2013. The IPD patients were two children and seven adults, three of whom died with a rapid disease progress. Although the clear transmission route was not determined, eight of the nine patients (89%) had close contact with children, which suggests that transmitted colonisation of Sp12F among children and adults might be the source of transmission. Continuous monitoring of IPDs, along with the determination of pneumococcal serotypes, is warranted in the post-13-valent PCV era. New IPD control strategies may be needed if this fatal outbreak continues to occur.

Entities:  

Keywords:  12F; 13-valent pneumococcal vaccine; Invasive pneumococcal infections; Japan

Mesh:

Year:  2018        PMID: 30070189      PMCID: PMC9506687          DOI: 10.1017/S0950268818002133

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   4.434


  14 in total

1.  Whole-Genome Sequencing Reveals the Origin and Rapid Evolution of an Emerging Outbreak Strain of Streptococcus pneumoniae 12F.

Authors:  Xianding Deng; Gisele Peirano; Erin Schillberg; Tony Mazzulli; Scott D Gray-Owen; John L Wylie; D Ashley Robinson; Salaheddin M Mahmud; Dylan R Pillai
Journal:  Clin Infect Dis       Date:  2016-02-07       Impact factor: 9.079

2.  Determination of normal splenic volume on computed tomography in relation to age, gender and body habitus.

Authors:  P Prassopoulos; M Daskalogiannaki; M Raissaki; A Hatjidakis; N Gourtsoyiannis
Journal:  Eur Radiol       Date:  1997       Impact factor: 5.315

3.  Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries.

Authors:  Hude Quan; Bing Li; Chantal M Couris; Kiyohide Fushimi; Patrick Graham; Phil Hider; Jean-Marie Januel; Vijaya Sundararajan
Journal:  Am J Epidemiol       Date:  2011-02-17       Impact factor: 4.897

Review 4.  Recent progress and concerns regarding the Japanese immunization program: addressing the "vaccine gap".

Authors:  Akihiko Saitoh; Nobuhiko Okabe
Journal:  Vaccine       Date:  2014-06-18       Impact factor: 3.641

5.  Whole-Genome Sequence Analysis of Streptococcus pneumoniae Strains That Cause Hospital-Acquired Pneumonia Infections.

Authors:  Bin Chang; Masatomo Morita; Ken-Ichi Lee; Makoto Ohnishi
Journal:  J Clin Microbiol       Date:  2018-04-25       Impact factor: 5.948

6.  Nationwide population-based surveillance of invasive pneumococcal disease in Japanese children: Effects of the seven-valent pneumococcal conjugate vaccine.

Authors:  Shigeru Suga; Bin Chang; Kazutoyo Asada; Hideki Akeda; Junichiro Nishi; Kenji Okada; Hiroshi Wakiguchi; Akihiko Maeda; Megumi Oda; Naruhiko Ishiwada; Akihiko Saitoh; Tomohiro Oishi; Mitsuaki Hosoya; Takehiro Togashi; Kazunori Oishi; Toshiaki Ihara
Journal:  Vaccine       Date:  2015-07-31       Impact factor: 3.641

7.  Scoring systems for prediction of mortality in patients with intensive care unit-acquired sepsis: a comparison of the Pitt bacteremia score and the Acute Physiology and Chronic Health Evaluation II scoring systems.

Authors:  Ji-Young Rhee; Ki Tae Kwon; Hyun Kyun Ki; Sang Yop Shin; Dong Sik Jung; Doo-Ryeon Chung; Byoung-Chun Ha; Kyong Ran Peck; Jae-Hoon Song
Journal:  Shock       Date:  2009-02       Impact factor: 3.454

8.  Serotypes, antimicrobial susceptibility, and molecular epidemiology of invasive and non-invasive Streptococcus pneumoniae isolates in paediatric patients after the introduction of 13-valent conjugate vaccine in a nationwide surveillance study conducted in Japan in 2012-2014.

Authors:  Satoshi Nakano; Takao Fujisawa; Yutaka Ito; Bin Chang; Shigeru Suga; Taro Noguchi; Masaki Yamamoto; Yasufumi Matsumura; Miki Nagao; Shunji Takakura; Makoto Ohnishi; Toshiaki Ihara; Satoshi Ichiyama
Journal:  Vaccine       Date:  2015-11-19       Impact factor: 3.641

9.  Emergence of Streptococcus pneumoniae Serotype 12F after Sequential Introduction of 7- and 13-Valent Vaccines, Israel.

Authors:  Assaf Rokney; Shalom Ben-Shimol; Zinaida Korenman; Nurith Porat; Zeev Gorodnitzky; Noga Givon-Lavi; Merav Ron; Vered Agmon; Ron Dagan; Lea Valinsky
Journal:  Emerg Infect Dis       Date:  2018-03       Impact factor: 6.883

10.  A Case of Waterhouse-Friderichsen Syndrome Resulting from an Invasive Pneumococcal Infection in a Patient with a Hypoplastic Spleen.

Authors:  Kazumasa Emori; Nobuhiro Takeuchi; Junichi Soneda
Journal:  Case Rep Crit Care       Date:  2016-01-28
View more
  2 in total

1.  Epidemiological and clinical features of invasive pneumococcal disease caused by serotype 12F in adults, Japan.

Authors:  Reiko Shimbashi; Bin Chang; Yoshinari Tanabe; Hiroaki Takeda; Hiroshi Watanabe; Tetsuya Kubota; Kei Kasahara; Kengo Oshima; Junichiro Nishi; Takaya Maruyama; Koji Kuronuma; Jiro Fujita; Tatsuki Ikuse; Yuki Kinjo; Motoi Suzuki; Anusak Kerdsin; Tomoe Shimada; Munehisa Fukusumi; Keiko Tanaka-Taya; Tamano Matsui; Tomimasa Sunagawa; Makoto Ohnishi; Kazunori Oishi
Journal:  PLoS One       Date:  2019-02-21       Impact factor: 3.240

2.  Streptococcus pneumoniae Serotype 12F-CC4846 and Invasive Pneumococcal Disease after Introduction of 13-Valent Pneumococcal Conjugate Vaccine, Japan, 2015-2017.

Authors:  Satoshi Nakano; Takao Fujisawa; Yutaka Ito; Bin Chang; Yasufumi Matsumura; Masaki Yamamoto; Shigeru Suga; Makoto Ohnishi; Miki Nagao
Journal:  Emerg Infect Dis       Date:  2020-11       Impact factor: 6.883

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.